Currently holds positions in Cerus Corp, Corcept Therapeutics Inc and Jazz Pharmaceuticals PLC
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Cerus Corp | Oct. 21, 2013 - |
Independent Director | Corcept Therapeutics Inc | June 1, 2015 - |
President, Chief Operating Officer | Jazz Pharmaceuticals PLC | Jan. 3, 2018 - |
President, Chief Executive Officer, Corporate Secretary, Director | Sunesis Pharmaceuticals Inc | Nov. 30, 2017 - Dec. 31, 2017 |
President, Chief Executive Officer, Interim Chief Financial Officer, Corporate Secretary | Sunesis Pharmaceuticals Inc | Jan. 1, 2016 - Nov. 30, 2017 |
Director | Ocugen Inc | June 18, 2015 - Jan. 1, 2016 |
President, Chief Executive Officer, Director | Sunesis Pharmaceuticals Inc | Aug. 1, 2005 - Jan. 1, 2016 |
Independent Director | Cerus Corp | June 27, 2011 - Oct. 21, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-03 | 2024-04-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
25.3055,660 USD |
2,200 -100.0% | 25.30 | 55,660 USD | |
2024-02-02 | 2024-02-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
22.0048,400 USD |
2,200 -100.0% | 22.00 | 48,400 USD | |
2024-01-04 | 2024-01-02 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
22.1148,642 USD |
2,200 -100.0% | 22.11 | 48,642 USD | |
2023-12-05 | 2023-12-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
25.4756,034 USD |
2,200 -100.0% | 25.47 | 56,034 USD | |
2023-11-03 | 2023-11-01 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
27.9661,512 USD |
2,200 -100.0% | 27.96 | 61,512 USD | |
2023-10-04 | 2023-10-02 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
2,200
-100.0%
27.3260,104 USD |
2,200 -100.0% | 27.32 | 60,104 USD | |
2023-09-06 | 2023-09-05 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
2,200
-100.0%
32.9072,380 USD |
2,200 -100.0% | 32.90 | 72,380 USD | |
2023-09-06 | 2023-09-01 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
1,550
-100.0%
32.7350,732 USD |
1,550 -100.0% | 32.73 | 50,732 USD | |
2023-08-09 | 2023-08-07 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
650
-100.0%
30.1619,601 USD |
650 -100.0% | 30.16 | 19,601 USD | |
2023-08-09 | 2023-08-07 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
2,200
-77.2%
30.1466,308 USD |
2,200 -77.2% | 30.14 | 66,308 USD | |
2023-05-30 | 2023-05-26 |
Cerus Corp
(CERS)
|
B Purchase |
5,000
+4.4%
1.919,535 USD |
5,000 +4.4% | 1.91 | 9,535 USD | |
2022-08-09 | 2022-08-08 |
Corcept Therapeutics Inc
(CORT)
|
S Sale |
15,385
-100.0%
28.32435,703 USD |
15,385 -100.0% | 28.32 | 435,703 USD | |
2021-02-18 | 2021-02-16 |
Cerus Corp
(CERS)
|
PS Planned sale |
10,000
-14.3%
7.7877,797 USD |
10,000 -14.3% | 7.78 | 77,797 USD | |
2021-01-21 | 2021-01-19 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
5,000
-100.0%
28.74143,687 USD |
5,000 -100.0% | 28.74 | 143,687 USD | |
2020-11-19 | 2020-11-17 |
Cerus Corp
(CERS)
|
S Sale |
10,000
-14.3%
6.2562,505 USD |
10,000 -14.3% | 6.25 | 62,505 USD | |
2020-10-21 | 2020-10-19 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
5,000
-100.0%
17.6688,301 USD |
5,000 -100.0% | 17.66 | 88,301 USD | |
2020-07-20 | 2020-07-17 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
5,000
-100.0%
16.4882,411 USD |
5,000 -100.0% | 16.48 | 82,411 USD | |
2020-05-27 | 2020-05-22 |
Corcept Therapeutics Inc
(CORT)
|
PS Planned sale |
5,000
-100.0%
16.1080,500 USD |
5,000 -100.0% | 16.10 | 80,500 USD | |
2020-02-06 | 2020-01-29 |
Cerus Corp
(CERS)
|
B Purchase |
1,000
+2.2%
4.154,150 USD |
1,000 +2.2% | 4.15 | 4,150 USD |